The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Metastasectomy offers survival benefits for metastatic non-clear cell renal cell carcinoma (non-ccRCC). This surgical approach improved progression-free survival (PFS) and overall survival (OS), particularly for patients without liver metastasis.
Area Of Science
- Oncology
- Surgical Oncology
- Renal Cell Carcinoma Research
Background
- Metastatic non-clear cell renal cell carcinoma (non-ccRCC) presents unique treatment challenges.
- Understanding the role of metastasectomy in improving outcomes for non-ccRCC is crucial.
Purpose Of The Study
- To evaluate the clinical benefits of metastasectomy in patients with metastatic non-clear cell renal cell carcinoma (non-ccRCC).
- To identify patient subgroups that may benefit most from metastasectomy.
Main Methods
- Retrospective analysis of 120 patients with metastatic non-ccRCC from 2008-2021.
- Comparison of outcomes (overall survival and progression-free survival) between patients who underwent metastasectomy and those who did not.
- Statistical analysis using Cox regression and Kaplan-Meier methods.
Main Results
- Patients undergoing metastasectomy alongside systemic therapy and radical nephrectomy showed significantly improved PFS (27.1 vs. 14.0 months) and OS (67.3 vs. 24.0 months) compared to those without metastasectomy.
- Benefits were particularly pronounced in patients without liver metastasis and those with metachronous metastasis.
- No serious perioperative complications were reported.
Conclusions
- Metastasectomy can be a beneficial treatment modality for select patients with metastatic non-ccRCC.
- The procedure offers significant improvements in PFS and OS, especially for patients without liver involvement or with metachronous disease.
- Metastasectomy is a safe procedure with low complication rates.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...